search
Back to results

Exercise and Genotype in Sub-acute Stroke

Primary Purpose

Stroke

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Cardiovascular training
Standard Therapy
Sponsored by
McGill University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke focused on measuring Stroke, Rehabilitation, Neurosciences, Exercise, Neuroplasticity, BDNF, Cardiovascular training, Motor function, HIIT, Genotype

Eligibility Criteria

40 Years - 80 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Individuals 40-80 years old
  • Who had a first-ever ischemic (cortical or subcortical) stroke confirmed by MRI/CT
  • Who had stroke 2 to 6 weeks prior to participation
  • With recordable motor-evoked potentials (MEPs) elicited with transcranial magnetic stimulation (TMS) from the affected hemisphere
  • With no serious musculoskeletal or neurological conditions other than stroke
  • With sufficient cognitive/communicative capacity to safely perform the protocols.

Exclusion Criteria:

  • Hemorrhagic stroke
  • Cognitive impairment/dysphasia affecting informed consent
  • Concurrently enrolled in another exercise program
  • Major psychiatric or previous neurological disease
  • Absolute contraindications to TMS or exercise

Sites / Locations

  • Jewish Rehabiliation Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Cardiovascular training

Standard Therapy

Arm Description

Cardiovascular training will comprise 4 weeks of moderate-to-vigorous continuous training followed by 4 weeks of progressive high-intensity interval training (HIIT) performed on recumbent steppers. This intervention will be performed in addition to the conventional standard therapy sessions. We will start with very moderate intensities and prepare participants for higher intensities. Introducing HIIT will allow us to use higher intensities over short bursts of exercise interspersed with periods of active rest. HIIT is more effective than continuous training to increase BDNF and we have shown that even a single bout of HIIT reduces interhemispheric imbalances in excitability and improves motor learning in chronic stroke.

Will comprise 8 weeks of the control protocol that includes regular sessions of physiotherapy, occupational therapy, and speech therapy.

Outcomes

Primary Outcome Measures

Cortico-spinal excitability
Single pulse motor-evoked potentials of transcranial magnetic stimulation protocol.
Intra-cortical inhibition
Paired-pulse motor-evoked potentials of transcranial magnetic stimulation protocol.
Intra-cortical facilitation
Paired-pulse motor-evoked potentials of transcranial magnetic stimulation protocol.

Secondary Outcome Measures

Brain-derived neurotrophic factor
5 ml of blood will be placed into lab tubes and centrifuged. Blood plasma will be pipetted into lab wells and stored in a -80 ̊C freezer for analysis with an ELISA kit sensitive to protein and mature BDNF.
Cardiorespiratory fitness
We will determine the maximum oxygen consumption (VO2peak) achieved during the graded exercise test as we have shown in previous studies.

Full Information

First Posted
September 21, 2021
Last Updated
October 20, 2023
Sponsor
McGill University
search

1. Study Identification

Unique Protocol Identification Number
NCT05076747
Brief Title
Exercise and Genotype in Sub-acute Stroke
Official Title
Promoting Brain Plasticity During Sub-acute Stroke: The Interactive Role of Exercise and Genotype
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Completed
Study Start Date
June 20, 2018 (Actual)
Primary Completion Date
July 1, 2023 (Actual)
Study Completion Date
August 1, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
McGill University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will investigate the impact of cardiovascular exercise on brain plasticity among patients in sub-acute stages after stroke, and whether genotype modulates the response to this intervention. Participants in the experimental group will perform cardiovascular training for 8 weeks, three times/week in addition to standard therapy, while participants in the control group will perform standard therapy only. Assessments will be performed at baseline, four weeks, and 8 weeks after training.
Detailed Description
Background: Research has shown that the adult human brain has an enormous plastic capacity to adapt after injury. In people who have recently experienced a stroke, interventions that promote brain plasticity in early stages after stroke can improve long-term recovery. Cardiovascular exercise is a simple strategy to increase brain plasticity and promote neural reorganization. However, there is no information about the effects of cardiovascular exercise on brain plasticity in early phases of stroke, despite the importance of this initial period for long-term recovery. Similarly, it is not known if, depending on their genetic profile, some people will be more responsive than others to this type of exercise. Objectives: To establish whether: 1) cardiovascular exercise improves brain plasticity during the initial phases of post-stroke recovery; 2) carrying a specific form of the BDNF gene modulates the response to cardiovascular exercise. Design: 70 participants will perform either a progressive high-intensity cardiovascular exercise program or low-intensity stretching and toning exercise program. Both groups will undergo 8 weeks of training performed 3 times per week. Assessments will be performed at the beginning, mid-point (4 weeks) and at the end of the training period (8 weeks). Methodology: Assessments: 1) brain plasticity by measuring changes in brain excitability, a marker of brain plasticity, with non-invasive brain stimulation; 2) BDNF levels by measuring the blood concentration of this protein; 3) Genotype by identifying the subtype of BDNF gene carried by each participant; 4) Cardiorespiratory fitness by assessing the performance during a graded exercise test. Statistical analysis: Differences between exercise and control groups on the primary endpoint of all outcomes will be analyzed with linear mixed models. Besides baseline scores, sex, age, and type of stroke (cortical or subcortical) will be included as covariates because they can affect brain plasticity and BDNF response. T1 scores will also be included to increase the efficiency of the model. The influence of genotype on changes in primary and secondary outcomes in the exercise group will be inspected with the Freedman-Schatzkin test, a powerful technique to identify mediators of change that can be used in small-scale exercise studies. Expected outcomes: Cardiovascular exercise will promote positive changes in brain excitability and will increase blood BDNF levels in individuals in the early phases of stroke recovery. However, the individual response to this type of exercise in relation to brain plasticity and BDNF levels will be influenced by the genotype of each participant. Relevance: It is important to establish whether cardiovascular exercise enhances brain reorganization early after stroke post-stroke and whether genetic factors may influence the response to this intervention. This will provide clinicians with useful information which will be essential to design more individualized exercise-based treatments to optimize functional recovery in individuals with stroke. Impact: The first weeks after a stroke are critical for functional recovery. After this initial period, the rate of recovery slows down and functional improvements become much more difficult to achieve. In Canada, health-care costs in the 6 months after stroke amount to $2.8 billion/year. Finding cost-effective rehabilitation strategies to promote recovery during the early phases post-stroke is essential to help patients return to an independent living.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
Stroke, Rehabilitation, Neurosciences, Exercise, Neuroplasticity, BDNF, Cardiovascular training, Motor function, HIIT, Genotype

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
70 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Cardiovascular training
Arm Type
Experimental
Arm Description
Cardiovascular training will comprise 4 weeks of moderate-to-vigorous continuous training followed by 4 weeks of progressive high-intensity interval training (HIIT) performed on recumbent steppers. This intervention will be performed in addition to the conventional standard therapy sessions. We will start with very moderate intensities and prepare participants for higher intensities. Introducing HIIT will allow us to use higher intensities over short bursts of exercise interspersed with periods of active rest. HIIT is more effective than continuous training to increase BDNF and we have shown that even a single bout of HIIT reduces interhemispheric imbalances in excitability and improves motor learning in chronic stroke.
Arm Title
Standard Therapy
Arm Type
Active Comparator
Arm Description
Will comprise 8 weeks of the control protocol that includes regular sessions of physiotherapy, occupational therapy, and speech therapy.
Intervention Type
Behavioral
Intervention Name(s)
Cardiovascular training
Other Intervention Name(s)
CT
Intervention Description
8 weeks of cardiovascular training
Intervention Type
Behavioral
Intervention Name(s)
Standard Therapy
Other Intervention Name(s)
ST
Intervention Description
8 weeks of Standard Therapy
Primary Outcome Measure Information:
Title
Cortico-spinal excitability
Description
Single pulse motor-evoked potentials of transcranial magnetic stimulation protocol.
Time Frame
8 weeks
Title
Intra-cortical inhibition
Description
Paired-pulse motor-evoked potentials of transcranial magnetic stimulation protocol.
Time Frame
8 weeks
Title
Intra-cortical facilitation
Description
Paired-pulse motor-evoked potentials of transcranial magnetic stimulation protocol.
Time Frame
8 weeks
Secondary Outcome Measure Information:
Title
Brain-derived neurotrophic factor
Description
5 ml of blood will be placed into lab tubes and centrifuged. Blood plasma will be pipetted into lab wells and stored in a -80 ̊C freezer for analysis with an ELISA kit sensitive to protein and mature BDNF.
Time Frame
8 weeks
Title
Cardiorespiratory fitness
Description
We will determine the maximum oxygen consumption (VO2peak) achieved during the graded exercise test as we have shown in previous studies.
Time Frame
8 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Individuals 40-80 years old Who had a first-ever ischemic (cortical or subcortical) stroke confirmed by MRI/CT Who had stroke 2 to 6 weeks prior to participation With recordable motor-evoked potentials (MEPs) elicited with transcranial magnetic stimulation (TMS) from the affected hemisphere With no serious musculoskeletal or neurological conditions other than stroke With sufficient cognitive/communicative capacity to safely perform the protocols. Exclusion Criteria: Hemorrhagic stroke Cognitive impairment/dysphasia affecting informed consent Concurrently enrolled in another exercise program Major psychiatric or previous neurological disease Absolute contraindications to TMS or exercise
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marc Roig, PhD
Organizational Affiliation
McGill University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Jewish Rehabiliation Hospital
City
Laval
State/Province
Quebec
ZIP/Postal Code
H7V 1R2
Country
Canada

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Results will be published in peer-review journals.

Learn more about this trial

Exercise and Genotype in Sub-acute Stroke

We'll reach out to this number within 24 hrs